electroCore Investor Relations Material
Latest events
Q2 2024
electroCore
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from electroCore Inc
Access all reports
electroCore Inc is a commercial-stage medical technology company that develops and markets non-invasive neuromodulation devices. Its primary product, a handheld device, uses electrical stimulation to target the vagus nerve for the treatment of various conditions, including migraines and cluster headaches. The company’s technology is designed to offer patients a non-drug, non-invasive alternative for pain management and neurological disorders. electroCore is also exploring the potential use of its platform in other therapeutic areas such as respiratory diseases and inflammatory conditions. The company is headquartered in Rockaway, New Jersey, and its shares are listed on the NASDAQ.
Key slides for electroCore Inc
Investor Presentation
electroCore Inc
Investor Presentation
electroCore Inc
Latest articles
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
ECOR
Country
🇺🇸 United States